Skip to main content
. Author manuscript; available in PMC: 2021 Aug 27.
Published in final edited form as: Int J Cancer. 2016 Mar 2;138(12):3011–3019. doi: 10.1002/ijc.30037

Figure 2.

Figure 2

(A) Preliminary screen of the impact of whole-body irradiation (5.5 Gy) or intraperitoneal cyclophosphamide (CP) chemotherapy (103 μg/gm bw) upon % survival and survival time following IV inoculation of mice with bolus of 105 L1210 cells. Mice received either a 5.5 Gy x-ray dose or intraperitoneal cyclophosphamide 24 hr following L1210 inoculation. (B) Cyclophosphamide dose-dependent improvement in survival in mice inoculated with 105 L1210 leukemia cells 24 hr before the indicated IP cyclophosphamide doses were administered. There were 8 mice per treatment group.